Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.48%115.77M | 34.25%110.9M | 32.92%95.85M | 8.55%320.85M | 8.47%81.29M | 1.61%84.83M | 19.49%82.61M | 6.03%72.11M | 50.61%295.58M | 26.41%74.94M |
| Cost of revenue | 37.39%105.68M | 35.87%101.01M | 31.34%86.45M | 7.68%289.96M | 7.94%72.87M | 0.15%76.92M | 17.06%74.34M | 7.11%65.82M | 55.96%269.27M | 29.48%67.51M |
| Gross profit | 27.62%10.09M | 19.62%9.89M | 49.38%9.4M | 17.41%30.89M | 13.30%8.42M | 18.32%7.91M | 46.90%8.27M | -4.11%6.29M | 11.45%26.31M | 4.00%7.43M |
| Operating expense | 15.87%5.59M | 30.79%6.02M | 25.68%5.2M | 14.45%18.86M | 26.14%4.69M | 21.43%4.83M | 16.81%4.6M | 7.73%4.14M | 7.90%16.48M | -22.05%3.72M |
| Selling and administrative expenses | 17.28%5.8M | 30.32%6.2M | 25.68%5.2M | 14.45%18.86M | 13.14%5.02M | 16.91%4.95M | 19.81%4.76M | 7.73%4.14M | 7.90%16.48M | --4.44M |
| -General and administrative expense | 17.28%5.8M | 30.32%6.2M | 25.68%5.2M | 14.45%18.86M | 13.14%5.02M | 16.91%4.95M | 19.81%4.76M | 7.73%4.14M | 7.90%16.48M | --4.44M |
| Total other operating income | 72.95%211K | 16.88%187K | ---- | -34.66%688K | -53.81%333K | -52.71%122K | 357.14%160K | 87.18%73K | --1.05M | --721K |
| Operating profit | 46.05%4.5M | 5.61%3.88M | 94.94%4.2M | 22.38%12.02M | 0.46%3.73M | 13.74%3.08M | 116.90%3.67M | -20.84%2.15M | 17.96%9.82M | 56.20%3.72M |
| Net non-operating interest income (expenses) | 91.18%-9K | 48.18%-57K | -28.77%-94K | 11.91%-438.87K | 5.52%-154K | 37.80%-102K | 9.84%-110K | -48.98%-73K | -432.80%-498.21K | -178.86%-163K |
| Non-operating interest income | 124.19%139K | 106.52%95K | 162.86%92K | -5.39%207.12K | 25.49%64K | 37.78%62K | -14.81%46K | -49.28%35K | -24.29%218.92K | --51K |
| Non-operating interest expense | -9.76%148K | -2.56%152K | 72.22%186K | -9.92%645.99K | 1.87%218K | -21.53%164K | -11.36%156K | -8.47%108K | 414.21%717.12K | 159.52%214K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 99.59K | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -81.86%107K | 179.56%589.87K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 81.86%-107K | ---- | ---- | ---- | ---- | -179.56%-589.87K | ---- |
| Other non-operating income (expenses) | 38.36%101K | 4.05%481.67K | 87.18%73K | 20.71%462.93K | ||||||
| Income before tax | 50.76%4.49M | 7.28%3.82M | 95.26%4.21M | 18.25%12.27M | 0.73%3.58M | 17.07%2.98M | 126.75%3.56M | -20.55%2.15M | 13.59%10.38M | 9.52%3.55M |
| Income tax | 59.47%1.33M | 18.31%1.23M | 107.04%1.29M | 19.39%3.61M | 13.39%1.11M | 69.51%834K | 49.21%1.04M | -26.99%625K | 19.33%3.03M | 25.39%978K |
| Net income | 47.36%3.16M | 2.70%2.59M | 90.45%2.91M | 17.77%8.66M | -4.08%2.47M | 4.49%2.14M | 188.98%2.52M | -17.57%1.53M | 11.39%7.35M | 4.50%2.58M |
| Net income continuous operations | 47.36%3.16M | 2.70%2.59M | 90.45%2.91M | 17.77%8.66M | -4.08%2.47M | 4.49%2.14M | 188.98%2.52M | -17.57%1.53M | 11.39%7.35M | 4.50%2.58M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net income attributable to the company | 47.36%3.16M | 2.70%2.59M | 90.45%2.91M | 17.77%8.66M | -4.08%2.47M | 4.49%2.14M | 188.98%2.52M | -17.57%1.53M | 11.39%7.35M | 4.50%2.58M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 47.36%3.16M | 2.70%2.59M | 90.45%2.91M | 17.77%8.66M | -4.08%2.47M | 4.49%2.14M | 188.98%2.52M | -17.57%1.53M | 11.39%7.35M | 4.50%2.58M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 36.36%0.0075 | -11.59%0.0061 | 60.47%0.0069 | 11.17%0.0229 | -13.89%0.0062 | -4.35%0.0055 | 181.63%0.0069 | -17.31%0.0043 | 11.35%0.0206 | 4.35%0.0072 |
| Diluted earnings per share | 36.36%0.0075 | -11.59%0.0061 | 60.47%0.0069 | 11.17%0.0229 | -38.89%0.0044 | -4.35%0.0055 | 181.63%0.0069 | -17.31%0.0043 | 11.35%0.0206 | 4.35%0.0072 |
| Dividend per share | 12.90%0.0035 | -2.94%0.0033 | 0 | 16.07%0.0065 | 0 | 10.71%0.0031 | 0.0034 | 0 | 100.00%0.0056 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.